Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) JOURNAL OF INFECTION 2017
Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report BMC RESEARCH NOTES 2017
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus CLINICAL MICROBIOLOGY AND INFECTION 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies LIVER INTERNATIONAL 2017
Ombitasvir/Paritaprevir/Ritonavir and dasabuvir combination treatment in patients with HIV/HCV co-infection: results of an italian compassionate use program CLINICAL INFECTIOUS DISEASES 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study THE LANCET. GASTROENTEROLOGY & HEPATOLOGY 2017
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL INFECTION 2017
Diplopia as isolated presentation of varicella zoster central nervous system reactivation JOURNAL OF NEUROVIROLOGY 2017
Case report: human papilloma virus type 120-related papillomatosis mimicking laryngeal carcinoma INFECTION 2017
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon PLOS ONE 2017
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2017
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains JOURNAL OF CLINICAL MICROBIOLOGY 2017
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 2017
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis JOINT BONE SPINE 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2017
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2017
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial PLOS ONE 2017
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA Journal of hepatologyJOURNAL OF HEPATOLOGY 2017

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma